×

Uh-oh, it looks like your Internet Explorer is out of date.

For a better shopping experience, please upgrade now.

Good Clinical Practice: Pharmaceutical, Biologics, and Medical Device Regulations and Guidance Documents Concise Reference; Volume 2, Guidance
     

Good Clinical Practice: Pharmaceutical, Biologics, and Medical Device Regulations and Guidance Documents Concise Reference; Volume 2, Guidance

by Mindy J. Allport-Settle
 

See All Formats & Editions

Selected FDA GCP/Clinical Trial Guidance Documents Grouped by Topic:
* FDA Overview and Orientation
* Introduction to GCP
* Part I: General
* Part II: Institutional Review Boards (IRBs) and Informed Consent
* Part III: Drugs and Biologics
* Part IV: Medical Devices
* Part V: Manufacturing Requirements for Investigational

Overview

Selected FDA GCP/Clinical Trial Guidance Documents Grouped by Topic:
* FDA Overview and Orientation
* Introduction to GCP
* Part I: General
* Part II: Institutional Review Boards (IRBs) and Informed Consent
* Part III: Drugs and Biologics
* Part IV: Medical Devices
* Part V: Manufacturing Requirements for Investigational Products
* Part VI: Electronic Data
Reference Tools
* Part VII: Combined Glossary and Index for all Quality Guidance Documents

Product Details

BN ID:
2940011814891
Publisher:
PharmaLogika
Publication date:
10/03/2010
Series:
Good Clinical Practice: Pharmaceutical, Biologics, and Medical Device Regulations and Guidance Documents Concise Referen , #2
Sold by:
Barnes & Noble
Format:
NOOK Book
Pages:
750
File size:
1 MB

Meet the Author

Following in the footsteps of Gordon Allport, all of Mindy J. Allport-Settle's books are built on a foundation of psychology and sociology with a focus on improving some aspect of industry through research and education.

Her career in healthcare began when she was a teenager working as an emergency medical technician. Since then, she has joined the U.S. Navy's advanced hospital corps, worked in organ and human tissue procurement, specialized in ophthalmology, and moved on to serve as a key executive, board member, and consultant for some of the best companies in the pharmaceutical, medical device, and biotechnology industry. She has provided guidance in regulatory compliance, corporate structuring, restructuring and turnarounds, new drug submissions, research and development and product commercialization strategies, and new business development. Her experience and dedication have resulted in international recognition as the developer of the only FDA-recognized and benchmarked quality systems training and development business methodology.

Her education includes a Bachelor's degree from the University of North Carolina, an MBA in Global Management from the University of Phoenix, and completion of the corporate governance course series in audit committees, compensation committees, and board effectiveness at Harvard Business School.

Customer Reviews

Average Review:

Post to your social network

     

Most Helpful Customer Reviews

See all customer reviews